Assessing the Safety of a Cell-Based Immunotherapy for Brain Cancers Using a Humanized Model of Hematopoiesis
Summary: Despite a surge in the preclinical development of immunotherapies, current models are unable to predict putative toxicity, particularly the “on-target, off-tumor” effects of these therapeutics. To address this gap, we used a humanized mouse model of hematopoiesis to examine the toxicity pro...
Main Authors: | Sabra K. Salim, Joshua Xu, Nicholas Wong, Chitra Venugopal, Kristin J. Hope, Sheila K. Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | STAR Protocols |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666166720301118 |
Similar Items
-
Advances in Immunotherapy for Adult Glioblastoma
by: Chirayu R. Chokshi, et al.
Published: (2021-07-01) -
The Strange Case of Jekyll and Hyde: Parallels Between Neural Stem Cells and Glioblastoma-Initiating Cells
by: David Bakhshinyan, et al.
Published: (2021-01-01) -
Advances in Human Immune System Mouse Models for Studying Human Hematopoiesis and Cancer Immunotherapy
by: Syed A. Mian, et al.
Published: (2021-02-01) -
Preclinical Testing of CAR T Cells in a Patient-Derived Xenograft Model of Glioblastoma
by: Nazanin Tatari, et al.
Published: (2020-12-01) -
The Deconvolution of Human Hematopoiesis
by: Michael D. Milsom
Published: (2018-12-01)